Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Mammon who wrote (11290)	5/18/2012 8:17:15 AM
From: NTTG	2 Recommendations Respond to of 13111

The claim is that the company knowingly over-projected sales based on their PIII trial results and market assessment. The question at hand is; when does the protection provided to forward looking statements under 'Safe Harbor' end and a fraudulent projection begin. Doubt the case will go far, Safe Harbor turns out to be a pretty generous umbrella. Best bet would be if someone disclosed internal documents indicating that clinical advisors and validated econ models fell well short of the descriptive phrases used in PR and other public documents. Otherwise, projections are just projections, not facts...buyer beware